Rabeprazole suppresses gastric acid secretion by inhibiting the gastric H+/K+-ATPase at the secretory surface of the gastric parietal cell. Because this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole has been characterized as a gastric proton-pump inhibitor.
Related products
-45%
Omeprazole
-15%
Kumudini Pharma Ltd.
-23%
Opsonin Pharmaceuticals Ltd.
-19%
Flucloxacillin Sodium
-24%
NIPRO JMI Pharmaceuticals Ltd.
-35%
Esomeprazole
-20%
Elemental Calcium + Vitamin D3 500 mg+200 IU
-13%
Flucloxacillin Sodium